Send mail to Author

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____      ___               _    _              _    _   
 / ____||   / _ \\    ____    | || | ||     ___   | || | || 
/ //---`'  | / \ ||  |    \\  | || | ||    /   || | || | || 
\ \\___    | \_/ ||  | [] ||  | \\_/ ||   | [] || | \\_/ || 
 \_____||   \___//   |  __//   \____//     \__ ||  \____//  
  `----`    `---`    |_|`-`     `---`       -|_||   `---`   
                     `-`                     `-`
 


Back to frontdoor view

OPUS4 Logo